WeReha - Magic PCP
Research type
Research Study
Full title
WeReha clinical protocol - CoRehab - Magic PCP Project
IRAS ID
238776
Contact name
Sharon Murphy
Contact email
Sponsor organisation
CoRehab
Duration of Study in the UK
1 years, 3 months, 18 days
Research summary
WeReha is an innovative device for the home rehabilitation of stroke survivors developed within the scope of the EU funded project MAGIC-PCP [5]. WeReha device is composed by an Android tablet running the dedicated software only, an inertial bluetooth sensor with 3D accelerometer, 3D gyroscope and 3D magnetometer, personal and disposable elastic straps to wear the sensor on the body and some objects that can become “smart” positioning the same sensor inside them. The WeReha software will propose the patient a series of rehabilitation exercises in the form of interactive games, either by using the sensor worn or in so called “smart objects”. A session with WeReha will always start with a questionnaire through which the software will understand the environment in which the patient is immersed, his/her daily health conditions, the presence or not of a caregiver throughout the session. Based on these responses, the software will automatically adapt the daily session to minimise risks while maintaining a high level of rehabilitation to reach the patient goals. The patient and eventually the caregiver will get reminders on their mobile/email to perform the exercises with WeReha, trying always to maintain a positive approach and to increase motivation.
The primary goal of this study is to assess the acceptance of a technology such as WeReha within stroke survivors, their caregivers and involved rehabilitation professionals, with all the related economic and logistical implications that may occur. Patients will be proposed to use WeReha in their home rehabilitation in addition to traditional treatments for at least 4 weeks and up to 12 weeks. Inclusion criteria are kept quite large in order to assess these factors on the largest scale possible and not limit the usage of the device to a specific group of patients. If patients enrolled are in a subacute phase (i.e. within the first 6 months after the stroke onset), they will be enrolled before leaving the hospital and reaching their home. If patients are considered as chronics (6 months after the onset), they will be enrolled during an outpatient treatment or on a voluntary basis after a wide research. Before leaving the hospital, every patient will receive proper training from a figure dedicated to the project, selected by the hospital and financially supported by the sponsor of the study.REC name
HSC REC A
REC reference
18/NI/0033
Date of REC Opinion
7 Mar 2018
REC opinion
Unfavourable Opinion